Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

198
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
198
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

292
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
292
Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

Endoscopic Procedures I: Esophagogastroduodenoscopy

346
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
346
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

156
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
156
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

156
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
156
Upper GI Series: Barium Swallow01:24

Upper GI Series: Barium Swallow

853
The Barium Swallow Study, or a Barium Esophagogram, is a diagnostic imaging method used to visualize the upper gastrointestinal (GI) tract, including the esophagus, stomach, and small intestine. It employs barium sulfate, a radiopaque contrast material, to provide clear images of the upper digestive system, helping to identify abnormalities, diseases, or structural issues.
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
853

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colitis Conundrum in <i>RPS29</i> Mutant Diamond Blackfan Anemia: Tacrolimus in Pediatric HSCT.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Clinical implementation of targeted panel sequencing for paediatric tumours: findings and outcomes in a Southeast Asian cohort.

Pathology·2026
Same author

Transient Elastography in Survivorship Care of Childhood ALL: Promise, but not yet a Practice Standard.

Indian pediatrics·2026
Same author

Chimerism kinetics in pediatric hematopoietic stem cell transplantation: from biological basis to advanced monitoring technologies.

Pediatric hematology and oncology·2026
Same author

Democratizing the Cure: Indigenous Innovations and the Future of Pediatric Cell and Gene Therapy in India.

Indian pediatrics·2026
Same author

A Machine-Based Learning Model for Recurrence Prediction and Timing After Endoscopic Eradication Therapy for Barrett's Esophagus.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Related Experiment Video

Updated: Sep 9, 2025

Diagnosis of Neoplasia in Barrett&#8217;s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.1K

New Approaches to Screening for Barrett Esophagus.

Nicholas Shaheen1, Prasad Iyer2, Swathi Eluri3

  • 1Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Gastroenterology & Hepatology
|September 2, 2025
PubMed
Summary

Barrett esophagus (BE) screening is insufficient. New methods like noninvasive tests and AI-driven risk assessment aim to improve early detection of esophageal adenocarcinoma (EAC) and reduce mortality.

Keywords:
Barrett esophagusesophageal adenocarcinomaesophageal mucosal visualizationmolecular biomarkersnoninvasive screening

More Related Videos

An Immunofluorescent Method for Characterization of Barrett&#8217;s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

528

Related Experiment Videos

Last Updated: Sep 9, 2025

Diagnosis of Neoplasia in Barrett&#8217;s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.1K
An Immunofluorescent Method for Characterization of Barrett&#8217;s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

528

Area of Science:

  • Gastroenterology
  • Oncology
  • Medical Diagnostics

Background:

  • Barrett esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC).
  • Current BE screening methods are inadequate, with low patient uptake and provider awareness.
  • Existing screening often overemphasizes gastroesophageal reflux disease (GERD) symptoms.

Purpose of the Study:

  • To review and highlight recent advancements in BE detection.
  • To explore novel noninvasive screening methods for BE.
  • To discuss strategies for improving risk stratification in BE screening.

Main Methods:

  • Review of emerging BE detection technologies including swallowable cell collectors, volatile organic compound analysis, and blood biomarkers.
  • Exploration of alternative visualization techniques like transnasal and capsule endoscopy.
  • Analysis of risk stratification strategies using machine learning and electronic health records.

Main Results:

  • Several novel noninvasive screening approaches are under investigation for BE detection.
  • Machine learning and EHR data offer enhanced risk stratification capabilities.
  • Integrated strategies combining noninvasive tests for low-risk and endoscopy for high-risk patients are proposed.

Conclusions:

  • Improved screening methods are crucial to reduce EAC incidence and mortality.
  • Noninvasive techniques and advanced risk stratification hold promise for BE detection.
  • Enhanced provider education and public health initiatives are needed to increase screening rates.